Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages : vimarsana.com

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

Related Keywords

United States , Wellington , New Zealand General , New Zealand , , Sei Investments Co , Wellington Management Group , Genetics Company Profile , Genetics Inc , Nasdaq , Earnest Partners , Goldman Sachs Group , Glenview Capital Management , Vanguard Group Inc , Myriad Genetics , Get Free Report , Genetics Stock Down , Capital Management , Management Group , Get Free , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily , Nasdaq Mygn , Mygn , Medical , 62855j10 , Ratings , Consensus ,